|
2024
|
Invention
|
Compounds and methods to sensitize cancer cells to cisplatin.
The present invention generally re... |
|
2023
|
Invention
|
Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors.
The present inven... |
|
|
Invention
|
Artemisinin derivatives.
The present invention generally relates to artemisinin/dihydroartemisin... |
|
2022
|
Invention
|
Tumor homing statin derivatives.
The present invention generally relates to tumor homing statin ... |
|
|
Invention
|
Heptamethine carbocyanine dye-cross-bridged tetraamine cyclam (ctc) chelator conjugates, their st... |
|
2021
|
Invention
|
Heptamethine carbocyanine dye-dota conjugates complexed with lutetium-177, yttrium-90, or gallium... |
|
|
Invention
|
Organic anion transporting peptide-based cancer imaging and therapy. A dye-drug conjugate for pre... |
|
2020
|
P/S
|
Pharmaceutical drug development services; Pharmaceutical research services |
|
2019
|
Invention
|
Organic anion transporting peptide-based cancer imaging and therapy.
Dye-drug conjugates and met... |
|
2017
|
Invention
|
Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors. The present invent... |
|
|
Invention
|
Compounds and methods to sensitize cancer cells to cisplatin. The present invention generally rel... |
